Home | english  | Impressum | Datenschutz | Sitemap | KIT

What a Difference a p(TA) Makes. Policy-Makers, Experts and the Public in Decision-Making on Risky Technologies

What a Difference a p(TA) Makes. Policy-Makers, Experts and the Public in Decision-Making on Risky Technologies
Autor:

E. Griessler, P. Biegelbauer

Link:
Quelle:

Nr. 3, 21. Jahrgang, S. 73-76

Datum: Dezember 2012

TA-Projekte

What a Difference a p(TA) Makes

Policy-Makers, Experts and the Public in Decision-Making on Risky Technologies

by Erich Griessler, Institute for Advanced Studies Vienna, and Peter Biegelbauer, Austrian Institute of Technology Vienna

It is almost a truism that technological innovation does not only hold great promises, but often involves substantial risks and even ethical problems. Thus, the question arises, who is going to decide on such ambiguous technologies in what way. The project CIT-PART studied comparatively the use and impact of participatory technology assessment (pTA) and expert-based technology assessment (TA) in science and technology policy in several EU Member States and organizations such as Austria (AT), Canada (CA), Denmark (DK), the European Commission (EC), Great Britain (GB), The Holy See (VA), Italy (IT), Latvia (LV), The Netherlands (NL), the OECD, Sweden (SE), and Switzerland (CH).

1    Introduction

In contrast to existing comparative studies on pTA (e.g. Bora/Hausendorf 2004; Decker/Ladikas 2004; Joly et al. 2001; Joss/Bellucci 2002), the project CIT-PART compared the use and impact of TA and pTA in the context of the same technology.[1] The main questions addressed in this project were: To what extent was TA and pTA used? Which factors facilitated and constrained pTA? What was the impact of TA and pTA on policy-making? How can pTA increase citizen participation on decision-making?

CIT-PART studied these questions by taking xenotransplantation policies in the 1990s and early 2000s as an example. Xenotransplantation involves the transplantation of cells, tissues and organs from animals to humans. It is representative of many contemporary technologies in the sense that it is a complex problem, possibly with huge potential benefits, but also risks and ethical challenges. It is therefore potentially controversial in the public.

In order to answer its research questions, in addition to wide-ranging analysis of literature and policy-documents, 135 expert interviews were carried out at the national and international level with policy-makers, experts, stakeholders and representatives of NGOs involved in TA and pTA.

2    Findings

Diversity of Policies

A diversity of xenotransplantation policies exists across Europe. They range from a wait and see position, in which no particular policies were formulated (AT), to permissive ones, which allowed clinical trials following approval by responsible authorities (CH, EC, GB, IT, LV, OECD, VA), and formal and informal moratoria on clinical trials (CA, DK, NL, SE).

Expert Advice Dominates

Expert TA dominated policy advice on xenotransplantation policies. Only a small minority of governments commissioned pTA to involve the public (CA, CH, NL). In some cases, academics initiated participatory exercises (AT, EC, and GB), however, these had no direct impact on decision-making in xenotransplantation policies.

Experts and Civil Servants are Critical Actors

In almost all of our cases, civil servants and experts were the most important actors in policy development (Biegelbauer et al. 2013). Elected politicians only contributed to policy-making in a few countries (CA, CH, DK, NL, SE). Despite the fact that reports repeatedly mentioned ethical issues as being of key importance, ethicists – either in the form of national ethics committees or single experts involved in TA and pTA – played a lesser role and became strongly involved in only a few cases (CA, GB, and VA). NGOs also took part in the political process in only a few countries (CA, CH, GB, and NL). Particularly animal welfare organizations faced difficulties to participate. In some cases, there was almost no public involvement beyond information being made public (AT, IT, LV, OECD, VA). By contrast, industry and science were able to considerably contribute as stakeholders to policy development. Citizens only became actively involved in xenotransplantation policies in a minority of countries (CA, CH, and NL).

Diversity of Framing, but Organ Shortage and Risk Often Dominate

First, xenotransplantation was not a controversial topic or the subject of hot debate in all cases.

  • In Austria and Latvia there was no debate at all.
  • In many cases xenotransplantation did not give rise to serious conflicts and was handled as “business as usual” (DK, EC, IT, OECD, SE, VA).
  • In the Netherlands and Switzerland a situation of managed tension arose.
  • However, in Canada and Great Britain, xenotransplantation was discussed in the context of a serious crisis of trust in government regulation.

Second, framing of xenotransplantation as a topic was contingent and varied between cases.

  • In most countries the topics of organ shortage and risk dominated the discussion.
  • In some cases xenotransplantation was discussed in the context of national economic competitiveness (CH, EC, GB, LV, OECD, and SE).
  • Less frequently ethical issues (CA, CH, SE, and VA) and animal welfare (CH, EC, NL, and VA) were critical and they became significant topics only in a few cases.
  • In two cases trust in government (CA, GB) became critical.
  • In one country xenotransplantation gave rise to struggles for competencies between parliament and government (NL).

Weak Role of the Public

The public was mostly involved in the weakest possible form, i. e. through surveys (in all cases except CH, LV, OECD, and VA). Additionally, with the exception of Austria, almost all countries informed the public in one way or another (Einsiedel et al. 2011). This was done to varying degrees, ranging from full-blown information campaigns (CA, CH, NL, SE) to simply publishing reports online (DK, EC, IT, OECD, VA). In a few cases the public was consulted. The intensity of consultation varied and was found to be very strong in some cases (CA, CH, GB, SE), strong in others (SE), or rather weak (EC, OECD). Again, the public was only involved in pTA exercises in CA, CH, and NL.

Little Direct but a Variety of Broader Impact of pTA

Although policy-makers approved – in all the cases in which pTA was carried out – of both the pTA itself and its results, no unambiguous direct impact of these exercises could be established. In the Netherlands, the results of the pTA were available only after xenotransplantation policies were adopted and the organizers of the pTA did not have concrete plans for feeding them into policy-making. As it turned out, pTA results and official xenotransplantation policies were congruent.

The same was true for Switzerland, where there was again an agreement between pTA results and government policies, which were determined before the end of the participatory exercise. In the Canadian case, it was hard to pinpoint a direct impact of the consultation exercise because the government did not make an official statement on its xenotransplantation policies, in accordance with the public opinion, thereafter no clinical trials were carried out.

However, adopting a perspective on impact assessment that goes beyond the mere handing over of a final report, all three pTAs had an impact on the development of xenotransplantation regulation. The pTAs contributed to creating public awareness of the issue and to a (re)configuration of the relationship between relevant actor groups. pTAs also played a part in the definition of xenotransplantation as an issue by legitimizing and giving authority to claims made and to actor positions in the debate and regulatory procedures. In all three cases, pTA exercises were by and large considered legitimate and meaningful ways to gain knowledge and to involve the public in a debate about science and technology policy (Griessler 2012; Loeber et al. 2011).

Varied Impact of TA as well

Difficulties in the integration of findings from assessment studies into policy-making are not restricted to pTA. Expert TA also faced difficulties in directly impacting on the regulation process. While in three of our cases the TA exercises had a strong impact on policy-making (DK, GB, and OECD), in another two cases direct impact was weaker or at best “mixed” (EC, VA). However, in three cases there was no direct impact on policy-making at all (IT, LV, SE). Important factors that co-determined a study’s impact were the kind of institution in which an advisory body is located, its mandate as advisory or regulatory body, the extent to which its connection to policy-making was institutionalized, and its reputation as a competent and independent organization. Moreover, the technical development of the policy issue and its framing in political and broader public debate played a role.

Facilitating Factors

The facilitating factors included existing traditions that pTA can build on, i. e. commissions involving participatory elements, adult education, direct democracy, consultation. They also included existing practices of accountability and openness, coordination with responsible policy-making authorities and departments, combinations of various methods (e.g. surveys, emails, plays, consensus conferences) and the involvement of the wider social and political context in the organization of pTA and dissemination of its results as well as the involvement of antagonistic groups in the pTA.

Constraining Factors

As the final finding the following factors may be mentioned. When a topic is not perceived as political at all because it is only framed as a scientific issue – excluding or postponing e.g. questions of collective risk, ethics, human rights, politics and economics – or considered as a matter of individual choice or when the public does not consider itself to be a legitimate actor vis-à-vis policy-makers and experts pTA was endangered. Contraining factors also included case-by-case decision-making on individual clinical trials, which undermine an understanding of xenotransplantation as a fundamentally political issue, traditions of paternalism, neo-corporatism and strong and exclusive links between elites from science and the civil service that exclude the public and a lack of infrastructure and funding.

Note

[1]  The project “Impact of Citizen Participation on Decision-Making in a Knowledge Intensive Policy Field” (CIT-PART) was active from January 2009 to June 2012. It was funded by the European Commission within the 7th Framework Programme for Research – Socioeconomic Sciences and Humanities (Contract Number: SSH-CT-2008-225327). We want to thank all partners in this research for their stimulating cooperation, i. e. Alexander Lang, Ingrid Metzler, Anna Pichelstorfer, Karina Weitzer (Institute for Advanced Studies); Edna Einsiedel, Mavis Jones, Meaghan Brierley (University of Calgary); Janus Hansen (Copenhagen Business School); Aivita Putnina and Jekatarina Kaleja (University of Latvia); Anne Loeber and Wytkse Versteeg (University of Amsterdam), Susanne Lundin and Kristofer Hansson (University of Lund); Nik Brown and Sian Beynon-Jones (University of York). For more information on the project see: http://www.cit-part.at.

References

Biegelbauer, P.; Griessler, E.; Loeber, A., 2013/forthcomming: Politik, öffentliche Verwaltung und Wissen: Wer prägt die Politikgestaltung ethisch und technisch komplexer Themen? In: dms – der moderne staat – Zeitschrift für Public Policy, Recht und Management

Bora, A.; Hausendorf, H., 2004: PARADYS. Participation and the Dynamics of Social Positioning. Final Report to the European Commission. Bielefeld

Decker, M.; Ladikas, M. (eds.), 2004: Bridges between Science, Society and Policy: Technology Assessment – Methods and Impacts. Berlin

Einsiedel, E.F.; Jones, M.; Brierley, M., 2011: Cultures, Contexts and Commitments in the Governance of Controversial Technologies: US, UK and Canadian Publics and Xenotransplantation Policy Development. In: Science and Public Policy 38/8 (2011), pp. 619–628

Griessler, E., 2012: One Size Fits All? The Institutionalization of Participatory Technology Assessment and its Relationship with National Ways of Policy-making. The Cases of Switzerland and Austria. In: Poiesis & Practice 9/1 (2012), pp. 61–80

Joly, P.B.; Assouline G., 2001: Assessing Public Debate and Participation in Technology Assessment in Europe. Final Report. June 2001 (Contract no. BIO-CT 980318); http://www.infra.fr/Internet/Directions/SED/science-gouvernance/pub/ADAPTA/adapta-pdg.pdf (download 2.12.09)

Joss, S.; Bellucci, S. (eds.), 2002: Participatory Technology Assessment. European Perspectives, Gateshead

Loeber, A.; Griessler, E.; Versteeg, W., 2011: Let’s Stop Looking up the Ladder. Assessing the Impact of Participatory Technology Assessment from a Network Perspective. In: Science and Public Policy 38/8 (2011), pp. 599–608

Kontakt

Dr. Erich Griessler
Institute for Advanced Studies
Stumpergasse 56, 1060 Vienna, Austria
Email: erich.griessler∂ihs.ac.at